Functional inactivation of pRb associated with Cyclin D1- and Cyclin-dependent kinase 4 overexpression plays a key role in human pituitary tumorigenesis

Korean Journal of Pathology

Volumn 43, Issue 1, 2009, Pages 56-62

  Myong, Na Hye ^a  

^a Dankook University College of Medicine   (South Korea)

Author keywords

Cyclin D1; Cyclin dependent kinase 4; Immunohistochemistry; Pituitary adenoma; Retinoblastoma protein

Indexed keywords

EID: 70349513069     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2009.43.1.56     Document Type: Article

References (24)

1. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998; 19: 798-827.
2. 1/S regulators is a frequent event in sporadic pituitary adenomas. Carcinogenesis 2001; 22: 1149-54.
3. INK4a/RB1 pathway is frequently deregulated in human pituitary adenomas. J Neuropathol Exp Neurol 2005; 64: 398-403.
4. Hibberts NA, Simpson DJ, Bicknell JE, et al. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res 1999; 5: 2133-9.
5. Farrell WE, Clayton RN. Molecular genesis of pituitary tumors. Frontiers in Neuropathol 2000; 21: 174-98.
6. Jordan S, Lidhar K, Korbonits M, Lowe DG, Grossman AB. Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol 2000; 143: R1-6.
7. Cryns V, Alexander JM, Klibanski A, Arnold A. The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 1993; 77: 644-6.
8. Bates AS, Farrell WE, Bicknell EJ, et al. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 1997; 82: 818-24.
9. Woloschak M, Yu A, Xiao J, Post KD. Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors. Int J Cancer 1996; 67: 16-9.
10. Simpson DJ, Magnay J, Bicknell JE, et al. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas. Cancer Res 1999; 59: 1562-6.
11. Dowdy SF, Hinds PW, Louie K, Reed SL, Arnold A, Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993; 73: 499-511.
12. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4A locus in tumor suppression and cell mortality. Cell 1996; 85: 27-37.
13. Sherr CJ. D type cyclins. Trends Biochem Sci 1995; 20: 187-90.
14. Connell-Crowley L, Harper JW, Goodrich DW. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 1997; 8: 287-301.
15. Knudsen ES, Wang JY. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 1997; 17: 5771-83.
16. Roesch A, Becker B, Meyer S, et al. Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma. Mod Pathol 2005; 18: 565-72.
17. Hardy J. Transsphenoidal microsurgical treatment of pituitary tumours. In: Linfoot J, ed. Recent advances in the diagnosis and treatment of pituitary tumours. New York: Raven Press, 1979; 375-88.
18. Betticher DC, White GR, Vonlanthen S, et al. G1 control gene status is frequently altered in resectable non-small cell lung cancer. Int J Cancer 1997; 74: 556-62.
19. Roncalli M, Bosari S, Marchetti A, et al. Cell cycle related gene abnormalities and product expression in oesophageal carcinoma. Lab Invest 1998; 78: 1049-57.
20. Palmero I, Peters G. Perturbation of cell cycle regulators in human cancer. Cancer Surv 1996; 27: 351-67.
21. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998; 19: 798-827.
22. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-7.
23. Betticher DC, Heighway J, Hasleton PS, et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary non-small cell lung cancer. Br J Cancer 1996; 73: 294-300.
24. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 1995; 55: 1613-6.